Pneumocystis Jirovecii Pneumonia on Certolizumab, Leflunomide, Methotrexate, and Prednisone Therapy for Rheumatoid Arthritis

被引：0
|
作者：
Berger, P. A. [1 ]
Helberg, S. [1 ]
Qua, D. C. [2 ]
Elshami, A. [3 ]
Yu, J. C. [4 ]
Bissoon, D. [3 ]
Rohr, S. [3 ]
Foss, N. [3 ]
Degroot, J. [3 ]
Meyers, M. [3 ]
机构：
[1] Sanford USD Med Ctr, Pulm Crit Care Neurocrit Care, Sioux Falls, SD USA
[2] Sanford Med Ctr, Sanford Pulm Clin, Sioux Falls, SD USA
[3] Sanford USD Med Ctr, Pulm Crit Care, Sioux Falls, SD USA
[4] Sanford Clin Pulm Med, Sioux Falls, SD USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6884
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pneumocystis carinii pneumonia associated with leflunomide therapy for rheumatoid arthritis
    Enzenauer, RJ
    Khan, KJ
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2002, 8 (01) : 64 - 65
  • [2] RHEUMATOID-ARTHRITIS, METHOTREXATE THERAPY, AND PNEUMOCYSTIS PNEUMONIA
    LEFF, RL
    CASE, JP
    MCKENZIE, R
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 112 (09) : 716 - 716
  • [3] A case of Pneumocystis Jirovecii pneumonia in a patient on Etanercept for Rheumatoid arthritis
    O'Dowd, E. L.
    Wahedna, I.
    Regan, M. R.
    Berg, R. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [4] PNEUMOCYSTIS-CARINII PNEUMONIA ASSOCIATED WITH METHOTREXATE THERAPY IN RHEUMATOID-ARTHRITIS
    FLOOD, DA
    CHAN, CK
    PRUZANSKI, W
    [J]. JOURNAL OF RHEUMATOLOGY, 1991, 18 (08) : 1254 - 1256
  • [5] PNEUMOCYSTIS-CARINII PNEUMONIA FOLLOWING METHOTREXATE THERAPY FOR RHEUMATOID-ARTHRITIS
    PERRUQUET, JL
    HARRINGTON, TM
    DAVIS, DE
    [J]. ARTHRITIS AND RHEUMATISM, 1983, 26 (10): : 1291 - 1292
  • [6] Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations
    Mori, Shunsuke
    Sugimoto, Mineharu
    [J]. CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2015, 9 : 29 - 40
  • [7] Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy
    Sakamoto, Noriho
    Hara, Shintaro
    Ishimoto, Hiroshi
    Nakashima, Shota
    Yura, Hirokazu
    Miyamura, Takuto
    Okuno, Daisuke
    Hara, Atsuko
    Kakugawa, Tomoyuki
    Yamaguchi, Hiroyuki
    Obase, Yasushi
    Kushima, Hisako
    Ishii, Hiroshi
    Noguchi, Shingo
    Kido, Takashi
    Kobayashi, Tsutomu
    Soejima, Yoshifumi
    Yoshioka, Sumako
    Ishimatsu, Yuji
    Yatera, Kazuhiro
    Kadota, Jun-ichi
    Mukae, Hiroshi
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 248 (03): : 209 - 216
  • [8] Serum Soluble Interleukin-2 Receptor Is a Candidate Marker Differentiating Pneumocystis Jirovecii Pneumonia and Methotrexate-Induced Pneumonia in Patients with Rheumatoid Arthritis Under Methotrexate Therapy
    Sakamoto, N.
    Hara, S.
    Ishimoto, H.
    Nakashima, S.
    Yura, H.
    Miyamura, T.
    Okuno, D.
    Hara, A.
    Kakugawa, T.
    Kushima, H.
    Ishii, H.
    Noguchi, S.
    Kido, T.
    Ishimatsu, Y.
    Yatera, K.
    Kadota, J.
    Mukae, H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [9] Factors Associated with Pneumocystis jirovecii Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study
    Ohmura, Shin-Ichiro
    Homma, Yoichiro
    Masui, Takayuki
    Miyamoto, Toshiaki
    [J]. INTERNAL MEDICINE, 2022, 61 (07) : 997 - 1006
  • [10] Methotrexate/prednisone/tocilizumabPneumocystis jirovecii pneumonia: case report
    [J]. Reactions Weekly, 2022, 1917 (1) : 365 - 365
12345